Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
KWS BioTest is an established contract research organization providing a wide range of drug discovery services spanning preclinical development from early cell biology, through efficacy models to clinical sample analysis.
At KWS BioTest we have extensive experience in mapping immune function in the clinic. We understand that in early phase clinical trials, biomarker efficacy data generated with only a small proportion of the clinical budget may crucially contribute to the decision to progress.
We identify and assess molecular indicators that confirm the drug is having an effect on its intended target. Through implementation of a validated set of analytical, cellular and even functional assays, as part of the clinical team in Phase 0-2 studies, we are able to confirm that the drug is engaging with the target and is having the effect predicted. In addition we are able to identify early warning signs related to immune toxicology if they are present.
Contact us at firstname.lastname@example.org for more information.